<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors></authors><secondary-authors><author><style face="normal" font="default" size="100%">,</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Correction: &lt;em&gt;CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells&lt;/em&gt;</style></title><secondary-title><style face="normal" font="default" size="100%">Journal for ImmunoTherapy of Cancer</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2021-08-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">1-1</style></pages><doi><style  face="normal" font="default" size="100%">10.1136/jitc-2019-000218corr1</style></doi><volume><style face="normal" font="default" size="100%">9</style></volume><issue><style face="normal" font="default" size="100%">8</style></issue><abstract><style  face="normal" font="default" size="100%">You do not have access to the full text of this article, the first page of the PDF of this article appears above.</style></abstract></record></records></xml>